MacroGenics is a biopharmaceutical company that develops antibody-based therapeutics for treatment of many forms of cancers, autoimmune disorders, and infectious diseases. Drug application submissions must adhere to very strict guidelines, including the Electronic Common Technical Document (eCTD) format to be considered. Application reviews can take nearly a year to process, meaning the document-processing work needs to be as efficient as possible so the drugs can be approved to hit the market faster.
MacroGenics turned to Litera Microsystems for its DocXtools for Life Sciences solution. DocXtools for Life Sciences is a Microsoft Word toolbar that accelerates the creation, review, and formatting of eCTDs by enforcing standards for content, style, and format. It gets documents submission-ready faster.
With DocXtools for Life Sciences, MacroGenics can now focus on delivering life-changing therapies to the market faster. In addition, the straightforward ease of document conversion allows users to spend their time more productively by providing formatting support and training.